Comprehensive comparison of molecular portraits between cell lines and tumors in breast cancer

被引:153
|
作者
Jiang, Guanglong [1 ,2 ]
Zhang, Shijun [1 ,2 ]
Yazdanparast, Aida [1 ,2 ]
Li, Meng [1 ,2 ]
Pawar, Aniruddha Vikram [1 ,2 ]
Liu, Yunlong [1 ,2 ]
Inavolu, Sai Mounika [1 ,2 ]
Cheng, Lijun [1 ,2 ]
机构
[1] Indiana Univ, Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46202 USA
[2] Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA
来源
BMC GENOMICS | 2016年 / 17卷
关键词
Heterogeneous; Breast cancer; DNA mutation; mRNA expression; Copy number alteration; Reverse-phase protein array; Molecular portraits; Cell lines; GENOME-WIDE ASSOCIATION; MUTATIONAL EVOLUTION; PROTEIN ABUNDANCE; GENE-EXPRESSION; MODELS; SUBTYPES; SIGNATURES; LANDSCAPE; DISCOVERY; RESOURCE;
D O I
10.1186/s12864-016-2911-z
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: Proper cell models for breast cancer primary tumors have long been the focal point in the cancer's research. The genomic comparison between cell lines and tumors can investigate the similarity and dissimilarity and help to select right cell model to mimic tumor tissues to properly evaluate the drug reaction in vitro. In this paper, a comprehensive comparison in copy number variation (CNV), mutation, mRNA expression and protein expression between 68 breast cancer cell lines and 1375 primary breast tumors is conducted and presented. Results: Using whole genome expression arrays, strong correlations were observed between cells and tumors. PAM50 gene expression differentiated them into four major breast cancer subtypes: Luminal A and B, HER2amp, and Basal-like in both cells and tumors partially. Genomic CNVs patterns were observed between tumors and cells across chromosomes in general. High C > T and C > G trans-version rates were observed in both cells and tumors, while the cells had slightly higher somatic mutation rates than tumors. Clustering analysis on protein expression data can reasonably recover the breast cancer subtypes in cell lines and tumors. Although the drug-targeted proteins ER/PR and interesting mTOR/GSK3/TS2/PDK1/ER_P118 cluster had shown the consistent patterns between cells and tumor, low protein-based correlations were observed between cells and tumors. The expression consistency of mRNA verse protein between cell line and tumors reaches 0.7076. These important drug targets in breast cancer, ESR1, PGR, HER2, EGFR and AR have a high similarity in mRNA and protein variation in both tumors and cell lines. GATA3 and RP56KB1 are two promising drug targets for breast cancer. A total score developed from the four correlations among four molecular profiles suggests that cell lines, BT483, T47D and MDAMB453 have the highest similarity with tumors. Conclusions: The integrated data from across these multiple platforms demonstrates the existence of the similarity and dissimilarity of molecular features between breast cancer tumors and cell lines. The cell lines only mirror some but not all of the molecular properties of primary tumors. The study results add more evidence in selecting cell line models for breast cancer research.
引用
收藏
页数:21
相关论文
共 50 条
  • [41] MFUM-BrTNBC-1, a Newly Established Patient-Derived Triple-Negative Breast Cancer Cell Line: Molecular Characterisation, Genetic Stability, and Comprehensive Comparison with Commercial Breast Cancer Cell Lines
    Skok, Kristijan
    Gradisnik, Lidija
    Celesnik, Helena
    Milojevic, Marko
    Potocnik, Uros
    Jezernik, Gregor
    Gorenjak, Mario
    Sobocan, Monika
    Takac, Iztok
    Kavalar, Rajko
    Maver, Uros
    CELLS, 2022, 11 (01)
  • [42] Comprehensive Molecular Landscape of Cetuximab Resistance in Head and Neck Cancer Cell Lines
    Gomes, Izabela N. F.
    da Silva-Oliveira, Renato J.
    da Silva, Luciane Sussuchi
    Martinho, Olga
    Evangelista, Adriane F.
    van Helvoort Lengert, Andre
    Leal, Leticia Ferro
    Silva, Viviane Aline Oliveira
    dos Santos, Stephanie Piancenti
    Nascimento, Flavia Caroline
    Lopes Carvalho, Andre
    Reis, Rui Manuel
    CELLS, 2022, 11 (01)
  • [43] The molecular mechanism of different sensitivity of breast cancer cell lines to TRAIL
    ZHANG Jindan
    ChineseScienceBulletin, 2004, (19) : 2047 - 2052
  • [44] Molecular cytogenetic analysis of 11 new breast cancer cell lines
    F Forozan
    R Veldman
    C A Ammerman
    N Z Parsa
    A Kallioniemi
    O-P Kallioniemi
    S P Ethier
    British Journal of Cancer, 1999, 81 : 1328 - 1334
  • [45] Molecular characterization of breast cancer cell lines by clinical immunohistochemical markers
    Mota, Andre de Lima
    Evangelista, Adriane Feijo
    Macedo, Taciane
    Oliveira, Renato
    Scapulatempo-Neto, Cristovam
    da Costa Vieira, Rene Aloisio
    Chiquitelli Marques, Marcia Maria
    ONCOLOGY LETTERS, 2017, 13 (06) : 4708 - 4712
  • [46] The molecular mechanism of different sensitivity of breast cancer cell lines to TRAIL
    Zhang, JD
    Liu, YX
    Liu, SL
    Zheng, DX
    CHINESE SCIENCE BULLETIN, 2004, 49 (19): : 2047 - 2052
  • [47] Understanding the molecular mechanisms of enzalutamide resistance in breast cancer cell lines
    Arroyo-Garrapucho, Nuria
    Garcia-Rodriguez, Sara
    Gestoso-Uzal, Nerea
    Herrero, Ana-Belen
    Gonzalez-Sarmiento, Rogelio
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 550 - 550
  • [48] Molecular characterization of breast cancer cell lines from young women
    Oltra, S. S.
    Pena-Chilet, M.
    Martinez, M. T.
    Llorca-Cardenosa, M. J.
    Tormo, E.
    Eroles, P.
    Lluch, A.
    Ribas, G.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S13 - S13
  • [49] Molecular cytogenetic analysis of 11 new breast cancer cell lines
    Forozan, F
    Veldman, R
    Ammerman, CA
    Parsa, NZ
    Kallioniemi, A
    Kallioniemi, OP
    Ethier, SP
    BRITISH JOURNAL OF CANCER, 1999, 81 (08) : 1328 - 1334
  • [50] Comprehensive molecular characterization of invasive lobular breast tumors
    Ciriello, Giovanni
    Gatza, Michael L.
    Hoadley, Katherine A.
    Zhang, Hailei
    Rhie, Suhn K.
    Bowlby, Reanne
    Wilkerson, Matthew D.
    Kandoth, Cyriac
    McLellan, Michael
    Cherniack, Andrew
    Laird, Peter W.
    Sander, Chris
    King, Tari A.
    Perou, Charles M.
    CANCER RESEARCH, 2015, 75